Outcomes of High-Dose Versus Low-Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation: A Randomized Controlled Trial
Journal of Intensive Care Medicine · 2024
DOI: 10.1177/08850666241250319 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Intensive Care Medicine, 2024. Verfasst von Tarek Mohamed Ashoor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain-Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Sepsis, Respiration, Artificial, Procalcitonin, Critical Illness. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Themen: Beatmung und Weaning, Sepsis
Abstract (Originalsprache)
Background
Critically ill patients with sepsis have a high incidence of vitamin D deficiency. Vitamin D promotes the synthesis of human cathelicidin antimicrobial peptide, a precursor of LL-37, which is a part of the innate immune system. This study investigated the effectiveness and safety of the early administration of high-dose enteral vitamin D 3 in comparison with low-dose vitamin D 3 in patients with sepsis requiring mechanical ventilation (MV).
Methods
Eighty adult patients with sepsis requiring MV with known vitamin D deficiency were randomly assigned to receive either an enteral 50 000 IU (Group I) or 5000 IU (Group II) vitamin D supplementation. Clinical and laboratory parameters were evaluated at baseline and on days 4 and 7 between the study groups. The change in serum procalcitonin (PCT) levels on day 7 was the primary outcome, while the change in serum LL-37 levels on day 7, changes in sequential organ failure assessment (SOFA) score, and clinical pulmonary infection score on day 7, MV duration, and hospital length of stay (LOS) were the secondary outcomes.
Results
The (day 7-day 0) change in serum PCT and LL-37 levels and SOFA score were significantly different in Group I ( P = .010, P < .001, and P < .001, respectively). The SOFA score was significantly different on days 4 and 7 in Group I ( P < .001 and P < .001, respectively). The incidence of early ventilator-associated pneumonia was significantly different between both treatment groups ( P = .025). The hospital LOS was shorter in Group I ( P < .001). No 25-hydroxyvitamin-D toxicity was observed in either group.
Conclusions
Early enteral administration of high-dose vitamin D 3 in critically ill patients with sepsis requiring MV along with standard treatment for sepsis decreased serum procalcitonin levels, increased serum LL-37 levels, and ameliorated illness severity scores.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
- Kafr El Sheikh General Hospital, Egypt.
- Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
ORCID-Profile: Ibrahim Mamdouh Esmat
Zitieren
APA
Ashoor, T. M., Abd Elazim, A. E. H., Mustafa, Z. A. E., Anwar, M. A., Gad, I. A., & Mamdouh Esmat, I. (2024). Outcomes of High-Dose Versus Low-Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation: A Randomized Controlled Trial. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666241250319
Vancouver
Ashoor TM, Abd Elazim AEH, Mustafa ZAE, Anwar MA, Gad IA, Mamdouh Esmat I. Outcomes of High-Dose Versus Low-Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation: A Randomized Controlled Trial. Journal of Intensive Care Medicine. 2024. doi:10.1177/08850666241250319
BibTeX
@article{Ashoor2024,
author = {Ashoor, Tarek Mohamed and Abd Elazim, Abd Elmoniem Hassan and Mustafa, Zakaria Abd Elaziz and Anwar, Maha Ahmad and Gad, Ihab Ahmad and Mamdouh Esmat, Ibrahim},
title = {Outcomes of High-Dose Versus Low-Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation: A Randomized Controlled Trial},
journal = {Journal of Intensive Care Medicine},
year = {2024},
doi = {10.1177/08850666241250319}
}
EUVIMED